Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-Free versus Opioid-Based Anaesthesia for Secondary Breast Free-Flap Reconstruction Surgery
2022-001139-98Phase 3Active
- Sponsor
- Institut Curie
- Start
- Apr 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine, lidocaine and remifentanil in breast cancer (2 arms), sponsored by Institut Curie. Primary endpoint: Morphine consumption during the first 48 hours postoperatively. Started Apr 2022; status: active.
02
Drugs
dexmedetomidinelidocaineremifentanil
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2022-001139-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001139-98.